Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27.9M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
+1.39M
-
Total reported value, excl. options
-
$615M
-
Value change
-
+$77.8M
-
Put/Call ratio
-
0.83
-
Number of buys
-
84
-
Number of sells
-
-44
-
Price
-
$44.99
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q2 2015
147 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q2 2015.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
of 27.9M outstanding shares and own 49.12% of the company stock.
Largest 10 shareholders include EAGLE ASSET MANAGEMENT INC (1.35M shares), Consonance Capital Management LP (1.24M shares), Apex Capital Management (1.16M shares), FMR LLC (953K shares), STATE STREET CORP (843K shares), Krensavage Asset Management, LLC (707K shares), BlackRock Fund Advisors (660K shares), Invesco Ltd. (569K shares), MCCLAIN VALUE MANAGEMENT LLC (442K shares), and Voya Investment Management LLC (372K shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.